文献速递造血干细胞移植与细胞治疗

移植前临床特征、生物学标志物与合并症指数对异基因造血干细胞移植后移植相关死亡的预测作用

Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT.
PubMed 文献 · Blood Adv · 2017-08-02

该前瞻性单中心研究纳入2006至2012年间178例首次接受异基因造血干细胞移植的患者,评估移植前临床变量、合并症指数评分及生物学标志物对移植相关死亡(TRM)的预测价值。多因素分析显示,仅供受者HLA不相合无关供者(HR 2.79,95%CI 1.19-6.58,P=0.019)和经年龄校正的受者端粒长度较短(HR 2.17,95%CI 1.03-4.57,P=0.041)与TRM独立相关。作者认为移植前年龄校正端粒长度可能是HSCT背景下预测TRM的有用新指标。

要点

  • HLA不相合无关供者与TRM独立相关(HR 2.79,95%CI 1.19-6.58,P=0.019)。
  • 经年龄校正的受者端粒长度较短与TRM独立相关(HR 2.17,95%CI 1.03-4.57,P=0.041)。
  • 移植前年龄校正端粒长度可能是预测allo-HSCT后TRM的新指标。

核心结论

  • 多因素分析中仅HLA不相合无关供者和经年龄校正的受者端粒长度较短与TRM独立相关。
  • 移植前年龄校正端粒长度可能是HSCT背景下预测TRM的有用新指标。

研究设计与样本

  • 前瞻性单中心研究,纳入2006至2012年间首次接受allo-HSCT且全部变量可用的178例患者。

主要发现

  • 多因素分析显示HLA不相合无关供者与TRM独立相关(HR 2.79,95%CI 1.19-6.58,P=0.019)。
  • 多因素分析显示经年龄校正的受者端粒长度较短与TRM独立相关(HR 2.17,95%CI 1.03-4.57,P=0.041)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Various pretransplant patient and disease characteristics are associated with treatment-related mortality (TRM) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, TRM cannot yet be satisfactorily predicted. We prospectively investigated the aggregate impact of pretransplant clinical variables (period, donor/recipient age, gender, cytomegalovirus status, disease risk, stem cell source, and HLA matching), comorbidity index scores (Hematopoietic Cell Transplantation Comorbidity Index), and biological markers (telomere length, ferritin, and C-reactive protein) on TRM in single-center patients receiving a first allo-HSCT. From 2006 to 2012, all variables were available for 178 patients. In multivariate analysis, only mismatched unrelated donor (hazard ratio [HR], 2.79; 95% confidence interval [CI], 1.19-6.58; P = .019) and shorter age-adjusted recipient telomere length (HR, 2.17; 95% CI, 1.03-4.57; P = .041) were independently associated with TRM. Pre-allo-HSCT age-adjusted telomere length thus appears to be a useful new predictor of TRM in the setting of HSCT.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Xhaard A, Cunha R, Busson M, et al. Clinical profile, biological markers, and comorbidity index as predictors of transplant-related mortality after allo-HSCT. Blood Adv. 2017. PMID: 29296781. doi:10.1182/bloodadvances.2017008094

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。